Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myo-inositol:D-chiro-inositol Ratios in PCOS
NCT03201601Phase 3Completed
- Sponsor
- LGC Biosearch Technologies
- Start
- Feb 2016
- Primary completion
- May 2017
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by LGC Biosearch Technologies. Primary endpoint: Pregnancy rate at 12 weeks. Started Feb 2016; status: completed.
Beyond the preview
Go deeper on NCT03201601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03201601.